@FiercePharma: Analysts: Effient won't be a blockbuster. Article | Follow @FiercePharma
> Pfizer's patent on its impotence drug, Viagra, was partially rejected after the U.S. Patent and Trademark Office said it wasn't different enough from a Chinese herb known as horny goat weed. Report
> A Birmingham, Alabama, man won a $25.16 million verdict Tuesday against Roche, after claiming its acne medicine led to inflammatory bowel disease. Report
> Abbott Laboratories offered to buy 20 percent more of Solvay Pharma India, the Indian subsidiary of the Belgian drug company Abbott just acquired. Report
> Denmark's Novo Nordisk has launched its new-generation Victoza drug for treatment of type 2 diabetes in the United States. Report
> AstraZeneca announced that the company provided $769.6 million in savings to 507,475 patients in 2009 through its specialised prescription saving programme AZ&Me. Report
> Berkshire Hathaway cut stakes in Johnson & Johnson, the world's largest maker of health-care products, and Procter & Gamble, the No. 1 consumer-products company, as Chairman Warren Buffett raised cash for the biggest acquisition of his career. Report
Biotech News
@FierceBiotech: Rigel scores blockbuster $1.24B pact with AstraZeneca. Report | Follow @FierceBiotech
@JohnCFierce: Time put Sam Waksal on its top 10 list of crooked CEOs. Report. If he raises $50M, biotech will forgive but never forget. Follow @JohnCFierce
> Johnson & Johnson's mid-stage trial for abiraterone--an oral drug which inspired a billion-dollar buyout less than a year ago--has produced another set of promising results for men with advanced, treatment-resistant prostate cancer.
> Flagship Ventures and Third Rock Ventures have joined hands to launch a new biotech company in Cambridge, MA, pumping a $35 million Series A round into a venture that will build on some cutting-edge science devoted to protein engineering and structural biology. Article
> San Diego-based Tioga Pharmaceuticals has rounded up $18 million to fund a late-stage trial which will enroll 600 patients with diarrhea predominant Irritable Bowel Syndrome. Tioga report
> CombinatoRx will be forced to wait at least until March 1 to hear if the FDA will approve its new pain drug Exalgo as regulators scramble to make up for the time lost to back-to-back blizzards. Report
And Finally... Gardasil protected most women from cervical cancer and homosexual men from anal cancer, according to new studies from Merck. Report